CA-CROSSFIT
At the conclusion of the 2020 Reebok CrossFit Games Open in October, CrossFit, Inc. will find the fittest man and woman in every eligible country participating in the worldwide CrossFit Open and crown them national champions. National champions automatically qualify for the 2020 Reebok CrossFit Games, held in August in Madison, Wisconsin. There, national champions will have the chance to compete with other Games athletes for $1.6M and the title of Fittest on Earth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191007005216/en/
What Are the CrossFit Games?
The CrossFit Games are a grueling, multi-day competition in which elite athletes, ages 14 to 60+, and teams from around the world compete in the ultimate test of fitness. The CrossFit Games are the Sport of Fitness, and well-rounded athletes train to be prepared for unknown events announced just before the competition. CrossFit movements are selected from gymnastics, powerlifting, Olympic lifting, running, rowing, and beyond.
Athletes arrive in Madison, Wisconsin, with almost no knowledge of the actual events, so their training has to cover a wider range of activities than any other professional sport. They are ranked during competition with their peers, and the winners are crowned Fittest on Earth after proving their fitness in a series of diverse events over the course of several days. The 2020 event will be the 13th annual edition of the CrossFit Games and the largest field of individual athletes ever. The total purse this year is more than $2.3M.
What Is the CrossFit Games Open?
The CrossFit Games Open is the largest fitness competition on Earth and the first of three competitions that form the CrossFit Games season: the Open, the Age Group Online Qualifier, and the Games. In the Open, hundreds of thousands of athletes from more than 15,000 CrossFit affiliates worldwide compete in a five-week test of fitness. This online competition is open to anyone in the world. Every week, from Oct. 10, 2019, to Nov. 11, 2019, athletes will complete a workout designed by CrossFit, Inc. to test cardiovascular/respiratory endurance, stamina, strength, flexibility, power, coordination, agility, balance, and accuracy.
Upon completion of the Open, the top 20 athletes worldwide, as well as the first-place male and female competitors from each eligible country, will earn invitations to compete at the 2020 Reebok CrossFit Games. Following the Open, top age group athletes from 14-17 and 35-60+ have a second online qualifier to earn an Age Group spot in the finals. Beyond these two online qualifiers, the only way for an athlete to guarantee a spot in the finals is to win one of the 28 Sanctionals™ (CrossFit competitions that are individually owned and operated).
CrossFit Games Open National Champions
The 2020 season will mark the second year in which CrossFit, Inc. awards the first-place man and woman in every eligible nation worldwide the opportunity to compete at the CrossFit Games.
In 2019, CrossFit crowned a total of 232 national champions hailing from 123 different countries. On Thursday, Aug. 1, 2019, the first day of competition in Madison, Wisconsin, 143 men and 117 women representing 114 countries took the field, becoming the most diverse field of athletes the CrossFit Games had ever seen.
From Afghanistan to Belgium, Egypt to Estonia, Kosovo to Kuwait — the National Champion Open qualifier gives athletes from nations where CrossFit is in its infancy the opportunity to evolve the sport and represent their countries on a worldwide stage.
There are virtually no barriers to entry for any athlete who wishes to represent their country at the 2020 Reebok CrossFit Games. No professional status or allegiance to a sport federation is required or even preferred. Athletes need only do the following:
- Register for the Open.
- Complete and video record all five Open workouts as prescribed over the course of the Open. Submit scores to games.crossfit.com.
Champions will be notified after the Leaderboard is set upon completion of the Open and after citizenship is verified.
About CrossFit, Inc.
CrossFit, Inc. is the developer and provider of the CrossFit® fitness program and a recognized worldwide leader in functional fitness. Founded by Greg Glassman and built on the foundations of constantly varied, high-intensity functional movements, education and collaborative competition, CrossFit-brand workouts develop strength and fitness while cultivating community and camaraderie in each of the more than 15,000 affiliated gyms in CrossFit’s global network. CrossFit, Inc. is a leading accredited certificate issuer for physical-training professionals worldwide and offers specialty certificate programs in addition to its core curriculum. CrossFit, Inc.’s health initiatives pursue an investigation into the ills of modern medicine and the willful abuse of the public’s trust in science. CrossFit, Inc. created and operates the CrossFit Games, an annual competition where elite athletes compete to be named the Fittest on Earth™. To learn more, visit www.CrossFit.com , Games.CrossFit.com , or http://www.youtube.com/CrossFitHQ.
CrossFit, Forging Elite Fitness, The Sport of Fitness and Fittest on Earth are registered trademarks or trademarks of CrossFit, Inc. in the U.S. and/or other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191007005216/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom